<p>1<b><sup>st</sup></b> transplantation: 5×10<sup>5</sup> WBMCs from WT or CL mice plus 5×10<sup>5</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) recipients (B6.SJL, CD45.1). (<b>A–B</b>) The percentage of CD45.2 donor cell in PB and BM at 4-week interval after transplantation. Data shown are mean ± SEM (n = 5–8). 2<sup>nd</sup> transplantation: sorted 5×10<sup>5</sup> CD45.2 cells from 1<sup>st</sup> recipients of WT or CL mice, plus 5×10<sup>5</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) recipients (B6.SJL, CD45.1). (<b>C–D</b>) The percentage of CD45.2 donor cell in PB and BM was analyzed every 4 weeks after transplantation. Data shown are mean ± SEM (**P<0.01, n = 3–4).</p
<p>Lethally irradiated CD45.1 mice were reconstituted with 2 x 10<sup>5</sup> BMC containing an equa...
<p>Transplantation conditions and engraftment levels of human CD45<sup>+</sup> cells after 22 weeks ...
<p>Lethally irradiated C57BL/6 CD45.2 Thy1.2 mice (10.5 Gy) were injected via tail vein with sorted ...
<p>1×10<sup>6</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) WT or CL mice. ...
<p>Third transplantation: 2×10<sup>5</sup> CD45.2 cells sorted from 2<sup>nd</sup> recipient WT or C...
deletion was induced 1 mo after transplantation by injecting the recipient mice with polyI:C every o...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Cohorts of NSG mice were irradiated with given a transplant of cord blood cells or G-CSF mobilize...
<p>(A) 50, 100 or 200 HSCs sorted from <i>Prep1<sup>+/+</sup></i> and <i>Prep1<sup>i/i</sup></i> FLs...
<p>Six-to eight week-old sublethally irradiated NSG mice were transplanted intra-femorally with non-...
<p>(A) Schematic representation of competitive transplantation. 2×10<sup>5</sup> BMN cells from Cre-...
<p>(A) Serial transplantation of BM cells. BM cells (5×10<sup>5</sup>) from <i>Tie2-Cre</i> (denoted...
<p>KTLS cells from C57BL/Ka CD45.1 Thy1.1 mice were injected via tail vein into lethally irradiated ...
<p>(<b>A</b>) Proportion of <i>Crebbp</i><sup><i>+/-</i></sup> cell-derived reconstitution (CD45.2<s...
<p>(A) 2×10<sup>6</sup> unfractionated BM cells from primary recipients were injected into secondary...
<p>Lethally irradiated CD45.1 mice were reconstituted with 2 x 10<sup>5</sup> BMC containing an equa...
<p>Transplantation conditions and engraftment levels of human CD45<sup>+</sup> cells after 22 weeks ...
<p>Lethally irradiated C57BL/6 CD45.2 Thy1.2 mice (10.5 Gy) were injected via tail vein with sorted ...
<p>1×10<sup>6</sup> CD45.1 WBMCs were transplanted into lethally irradiated (9.5 Gy) WT or CL mice. ...
<p>Third transplantation: 2×10<sup>5</sup> CD45.2 cells sorted from 2<sup>nd</sup> recipient WT or C...
deletion was induced 1 mo after transplantation by injecting the recipient mice with polyI:C every o...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Cohorts of NSG mice were irradiated with given a transplant of cord blood cells or G-CSF mobilize...
<p>(A) 50, 100 or 200 HSCs sorted from <i>Prep1<sup>+/+</sup></i> and <i>Prep1<sup>i/i</sup></i> FLs...
<p>Six-to eight week-old sublethally irradiated NSG mice were transplanted intra-femorally with non-...
<p>(A) Schematic representation of competitive transplantation. 2×10<sup>5</sup> BMN cells from Cre-...
<p>(A) Serial transplantation of BM cells. BM cells (5×10<sup>5</sup>) from <i>Tie2-Cre</i> (denoted...
<p>KTLS cells from C57BL/Ka CD45.1 Thy1.1 mice were injected via tail vein into lethally irradiated ...
<p>(<b>A</b>) Proportion of <i>Crebbp</i><sup><i>+/-</i></sup> cell-derived reconstitution (CD45.2<s...
<p>(A) 2×10<sup>6</sup> unfractionated BM cells from primary recipients were injected into secondary...
<p>Lethally irradiated CD45.1 mice were reconstituted with 2 x 10<sup>5</sup> BMC containing an equa...
<p>Transplantation conditions and engraftment levels of human CD45<sup>+</sup> cells after 22 weeks ...
<p>Lethally irradiated C57BL/6 CD45.2 Thy1.2 mice (10.5 Gy) were injected via tail vein with sorted ...